awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38848273-1334342E-8DD6-45D4-9CA9-239ABA0227EA
Q38848273-1334342E-8DD6-45D4-9CA9-239ABA0227EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38848273-1334342E-8DD6-45D4-9CA9-239ABA0227EA
Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms.
P2860
Q38848273-1334342E-8DD6-45D4-9CA9-239ABA0227EA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38848273-1334342E-8DD6-45D4-9CA9-239ABA0227EA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
710f71cbc5556c5b6131961c9b9f6cfa04aa6f35
P2860
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.